Medicines industry acknowledges contribution of Senator Kim Carr
Medicines Australia chief executive Dr Brendan Shaw has congratulated the outgoing Minister for Manufacturing Senator Kim Carr on his legacy of achievement and contribution to industry and innovation policy.
Senator Carr was today sworn in as Minister for Human Services, after four and a half years as Minister for Innovation, Industry, Science and Research and latterly Minister for Manufacturing.
Dr Shaw said Senator Carr had been a consistently passionate advocate for industry generally, and for the Australian medicines industry in particular.
“Senator Carr has long been committed to maintaining and growing an innovative industrial base in Australia and has made a positive contribution to ensuring a viable operating environment for the Australian medicines industry,” Dr Shaw said.
“He has led the clinical trials reform agenda which seeks to ensure that Australia remains competitive in attracting global investment in clinical trials.
“The R&D tax credit legislation, which he stewarded through Parliament, will effectively reduce by 10 per cent the cost of conducting eligible R&D in Australia.
“Senator Carr has also advocated the importance of patent protection, and championed the Raising the Bar Bill, which is currently before the Parliament and which will bring Australia’s intellectual property regime into line with world standards.
“And he established the Pharmaceuticals Industry Strategy Group to develop a blueprint for a sustainable pharmaceuticals industry in Australia.
“I congratulate him on this record of achievement during his time in the Innovation and Manufacturing portfolios and I look forward to working with him as the new Minister for Human Services.”
Media Communications Manager
Phone: 0419 220 293